A.K. Pharma

A.K. Pharma

HER2 low breast cancer medicine

Enhertu® (Trastuzumab Deruxtecan)

Trastuzumab Deruxtecan 100mg Injection — HER2-Targeted Antibody-Drug Conjugate for HER2-Positive and HER2-Low Breast Cancer, Gastric Cancer and HER2-Mutant NSCLC